T Cell Receptor Peptide Therapy Triggers Autoregulation of Experimental Encephalomyelitis-Reference-Cited by-同舟云学术

T Cell Receptor Peptide Therapy Triggers Autoregulation of Experimental Encephalomyelitis

Published:1991-01-25 Issue:4992 Volume:251 Page:430-432
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Offner Halina¹,Hashim George A.²,Vandenbark Arthur A.¹

Affiliation:

1. Neuroimmunology Research 151D, Veterans Administration Medical Center, and Departments of Neurology, and Microbiology and Immunology (AAV), Oregon Health Sciences University, Portland, OR 97201.

2. Department of Microbiology and Surgery, St. Luke's Roosevelt Hospital, and Columbia University, New York, NY 10025.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference28 articles.

1. ACHAORBEA, H, T-CELL RECEPTORS IN MURINE AUTOIMMUNE-DISEASES, ANNUAL REVIEW OF IMMUNOLOGY 7: 371 (1989).

2. ACHAORBEA, H, LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION, CELL 54: 263 (1988).

3. BENNUN, A, THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS, EUROPEAN JOURNAL OF IMMUNOLOGY 11: 195 (1981).

4. BERNARD, CCA, SUPPRESSOR T CELLS PREVENT EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN MICE, CLINICAL AND EXPERIMENTAL IMMUNOLOGY 29: 100 (1977).

5. BURNS, F.R., BOTH RAT AND MOUSE T-CELL RECEPTORS SPECIFIC FOR THE ENCEPHALITOGENIC DETERMINANT OF MYELIN BASIC-PROTEIN USE SIMILAR V-ALPHA AND V-BETA CHAIN GENES EVEN THOUGH THE MAJOR HISTOCOMPATIBILITY COMPLEX AND ENCEPHALITOGENIC DETERMINANTS BEING RECOGNIZED ARE DIFFERENT, JOURNAL OF EXPERIMENTAL MEDICINE 169: 27 (1989).

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy;Small;2022-03

2. Molecular Interventions towards Multiple Sclerosis Treatment;Brain Sciences;2020-05-15

3. Peptide-Based Vaccination Therapy for Rheumatic Diseases;Journal of Immunology Research;2020-03-18

4. Novel Molecular Leads for the Prevention of Damage and the Promotion of Repair in Neuroimmunological Disease;Frontiers in Immunology;2019-07-19

5. Peptides Against Autoimmune Neurodegeneration;Current Medicinal Chemistry;2017-07-04